Publication | Closed Access
Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for the treatment of Alzheimer’s disease
118
Citations
46
References
2015
Year
Neurodegenerative DiseasesAlzheimer's DiseaseDual-target DrugAcetylcholinesterase ActivityMedicineNeuropharmacologyDegenerative PathologyAlzheimer ’NeuroprotectionNeurologyNeuroscienceProtein MisfoldingPharmacologyDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1